Vildaray M

Composition

Vildagliptin 50 mg + Metformin hydrochloride 500 mg (SR/ER) tablet

Uses of Vildaray M

Type 2 diabetes mellitus (T2DM) in adults, to improve glycaemic control when diet and exercise are not enough; used when metformin alone is inadequate or as combination therapy as advised by physician.

• •Lowers fasting and post-meal blood sugar
• •Improves insulin response in a glucose-dependent manner
• •Helps reduce hepatic glucose output
• •Lower hypoglycaemia risk vs some combinations (unless with insulin/SU)
• •Convenient combination therapy to improve HbA1c

How it works

Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), leading to glucose-dependent increase in insulin release and reduced glucagon. Metformin reduces hepatic glucose production and improves insulin sensitivity, lowering blood glucose without causing significant hypoglycaemia when used alone.

Directions for use

Oral tablet. Take exactly as prescribed, usually with meals to reduce stomach upset. Swallow whole (especially if SR/ER); do not crush/chew. Typical use is once or twice daily depending on strength and glycaemic targets.

Side effects

Common side effects of Vildaray M may include:

• •Nausea
• •vomiting
• •diarrhoea